Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 5/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
| ▸ | PRNP | P04156 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.30 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4073945 | 0.90 | PDK2 (0.36) | PDK2 | |
| SCHEMBL14912402 | 0.87 | CRHBP (0.39) | PDK2PGR | |
| SCHEMBL12560750 | 0.85 | PTGS2 (0.37) | PDK2PTGS2PGRPRNPPPARG | |
| SCHEMBL3222953 | 0.82 | PDK2 (0.44) | PDK2PGR | |
| SCHEMBL4071420 | 0.82 | MAOB (0.38) | — | |
| SCHEMBL13855113 | 0.81 | PTGS2 (0.35) | PDK2PTGS2PGRPRNPPPARG | |
| SCHEMBL3220300 | 0.81 | CYP2A6 (0.39) | PTGS2PRNPPPARGRXFP1NR2E3 | |
| SCHEMBL4570793 | 0.81 | ALOX5 (0.46) | PGR | |
| SCHEMBL10034424 | 0.81 | MCL1 (0.40) | PDK2PPARG | |
| SCHEMBL29793909 | 0.80 | PDK2 (0.43) | PDK2PTGS2PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100039027-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-2113954-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Idemitsu Kosan Co., Ltd. (JP) | 2009-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100039027-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | RUVBL2, KCNB2, KCNB1 | PDK2 2554/4885PTGS2 4471/4885PGR 2371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.